Comparing Guidelines for the Treatment of Inflammatory Bowel Disease
被引:0
|
作者:
Hanauer, Stephen B.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Chicago Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USAUniv Chicago Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA
Hanauer, Stephen B.
[1
]
Kirsner, Joseph B.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Chicago Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USAUniv Chicago Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA
Kirsner, Joseph B.
[1
]
机构:
[1] Univ Chicago Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA
As we enter into the era of 'personalized medicine', many of the recommendations of 'evidence-based medicine' require scrutiny and adaptation to optimize individual outcomes. Several examples of these discrepancies are exemplified by the topics of aminosalicylate use in Crohn's disease, early use of biologic agents that target TNF and the role of calcineurin inhibitors versus anti-TNF agents in steroid-refractory ulcerative colitis. (C) 2013 S.Karger AG, Basel
机构:
Univ Ulsan, Childrens Hosp, Asan Med Ctr, Coll Med,Dept Pediat, Seoul, South KoreaUniv Ulsan, Childrens Hosp, Asan Med Ctr, Coll Med,Dept Pediat, Seoul, South Korea